Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T11:43:09.065Z Has data issue: false hasContentIssue false

Schizophrenia with the 22q11.2 deletion and additional geneticdefects: case history

Published online by Cambridge University Press:  02 January 2018

M. Toyosima
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama
M. Maekawa*
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama
T. Toyota
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama
Y. Iwayama
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama
M. Arai
Affiliation:
Project for Schizophrenia Research, Tokyo Institute of Psychiatry, Tokyo
T. Ichikawa
Affiliation:
Project for Schizophrenia Research, Tokyo Institute of Psychiatry, Tokyo
M. Miyashita
Affiliation:
Project for Schizophrenia Research, Tokyo Institute of Psychiatry, Tokyo
T. Arinami
Affiliation:
Department of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki
M. Itokawa
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, and Project for Schizophrenia Research, Tokyo Institute of Psychiatry, Tokyo
T. Yoshikawa
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
*
Motoko Maekawa, Laboratory for Molecular Psychiatry RIKENBrain Science Institute, 2-1 Hirosawa, Wako-city, Saitama 351-0198, Japan.Email: mmaekawa@brain.riken.jp
Rights & Permissions [Opens in a new window]

Summary

The 22q11.2 deletion is the most prominent known genetic risk factor forschizophrenia, but its penetrance is at most approximately 50% suggestingthat additional risk factors are required for disease progression. Weexamined a woman with schizophrenia with this deletion for such riskfactors. She had high plasma pentosidine levels (‘carbonyl stress’) and aframeshift mutation in the responsible gene, GLO1. She alsohad a constant exotropia, so we examined the PHOX2B geneassociated with both schizophrenia and strabismus, and detected a 5-alaninedeletion. We propose that the combination of these genetic defects may haveexceeded the threshold for the manifestation of schizophrenia.

Information

Type
Short report
Copyright
Copyright © Royal College of Psychiatrists, 2011 
Supplementary material: PDF

Toyosima et al. supplementary material

Supplementary Figure S1-S2

Download Toyosima et al. supplementary material(PDF)
PDF 976.3 KB

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.